Back to search

United Kingdom· GB-APID-34176511000001100

Olmesartan medoxomil 40mg tablets

A medicinal product containing olmesartan, registered in United Kingdom by Actavis UK Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedOlmesartan medoxomil 40mg tabletsATC—REGISTER NO.GB-APID-3417651100000…PACKS LISTED2CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Olmesartan
Manufacturer
Actavis UK Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5012617026774
  • gtin
    05012617026774

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bdaba2ea-1ba9-43c9-963c-93d665204c4c
GET /v1/drugs/bdaba2ea-1ba9-43c9-963c-93d665204c4c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "34176511000001100",
  "desc": "Olmesartan medoxomil 40mg tablets (Actavis UK Ltd)",
  "form": "Oral tablet",
  "vpid": "42378811000001101",
  "source": "dmd",
  "vtm_id": "776982004",
  "strength": "40 mg",
  "substance": "Olmesartan",
  "ingredient": "Olmesartan medoxomil",
  "supplier_code": "3875201000001104"
}

See everything about olmesartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.